Assets Veränderung Datum
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Avrobio USD 110.52M 23.31M 2023-09
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Capricor Therapeutics USD 37.15M 8.86M 2023-09
Daiichi Sankyo JPY 2.65T 33.03B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Lumos Pharma USD 47.75M 8.62M 2023-09
Moderna USD 18.43B 1.02B 2023-12
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Novavax USD 1.66B 27.89M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Sarepta Therapeutics Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.